Mar. Drugs 2012, 10, 234-241; doi:10.3390/md10010234 OPEN ACCESS Marine Drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Short Note Antibacterial Bisabolane-Type Sesquiterpenoids from the Sponge-Derived Fungus Aspergillus sp. Dan Li 1, Ying Xu 2, Chang-Lun Shao 1,*, Rui-Yun Yang 3, Cai-Juan Zheng 1, Yi-Yan Chen 1, Xiu-Mei Fu 1, Pei-Yuan Qian 2, Zhi-Gang She 4, Nicole J. de Voogd 5 and Chang-Yun Wang 1,* 1 Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; E-Mails: [email protected] (D.L.); [email protected] (C.-J.Z.); [email protected] (Y.-Y.C.); [email protected] (X.-M.F.) 2 KAUST Global Academic Partnership Program, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China; E-Mails: [email protected] (Y.X.); [email protected] (P.-Y.Q.) 3 Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Education, School of Chemistry & Chemical Engineering, Guangxi Normal University, Guilin 541004, China; E-Mail: [email protected] 4 School of Chemistry and Chemical Engineering, Sun Yat-sen University, Guangzhou 510275, China; E-Mail: [email protected] 5 Netherlands Centre for Biodiversity Naturalis, P.O. box 9517, Leiden 2300 RA, The Netherlands; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mails: [email protected] (C.-L.S.); [email protected] (C.-Y.W.); Tel.: +86-532-8203-1536 (C.-Y.W.); Fax: +86-532-8203-1381 (C.-L.S.). Received: 20 November 2011; in revised form: 19 December 2011 / Accepted: 22 December 2011 / Published: 19 January 2012 Abstract: Four new bisabolane-type sesquiterpenoids, aspergiterpenoid A (1), (−)-sydonol (2), (−)-sydonic acid (3), and (−)-5-(hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H- pyran-2-yl)phenol (4) together with one known fungal metabolite (5) were isolated from the fermentation broth of a marine-derived fungus Aspergillus sp., which was isolated from the sponge Xestospongia testudinaria collected from the South China Sea. Four of them (1–4) are optically active compounds. Their structures and absolute configurations were elucidated by using NMR spectroscopic techniques and mass spectrometric analysis, and by comparing their optical rotations with those related known analogues. Compounds 1–5 Mar. Drugs 2012, 10 235 showed selective antibacterial activity against eight bacterial strains with the MIC (minimum inhibiting concentrations) values between 1.25 and 20.0 µM. The cytotoxic, antifouling, and acetylcholinesterase inhibitory activities of these compounds were also examined. Keywords: bisabolane-type sesquiterpenoid; antibacterial; sponge-derived fungus; Aspergillus sp. 1. Introduction Several bisabolane-type phenolic sesquiterpenoids have been isolated from marine materials, such as the gorgonian coral Pseudopterogorgia rigida [1], the sponges Didiscus flavus [2] and Myrmekioderma styx [3], the marine-derived fungi Verticillium tenerum [4], Aspergillus sp. [5] and Aspergillus sydowii [6]. These compounds have received much attention because of their multiple potent biological activities including the acetylcholinesterase inhibitory activity [7], antioxidant activity [8], cytotoxic activity [9], and antibacterial activity [10]. As part of our ongoing investigation on new natural antibacterial, cytotoxic, and nontoxic antifouling agents from marine fungi in the South China Sea [5,11–13], the EtOAc extract of a fermentation broth of the fungus Aspergillus sp. isolated from the sponge Xestospongia testudinaria attracted our attention because the extract showed significant antibacterial activity. The crude EtOAc extract of the fungal culture was subjected to silica gel column chromatography, Sephadex LH-20 and further semi-preparative HPLC, and this led to the isolation of five bisabolane-type sesquiterpenoids, including four new compounds, aspergiterpenoid A (1), (−)-sydonol (2), (−)-sydonic acid (3), (−)5-(hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H-pyran-2-yl)phenol (4), and one known compound, (Z)-5-(hydroxymethyl)-2-(6′-methylhept-2′-en-2′-yl)phenol (5) [14]. Their structures were elucidated using NMR spectroscopic techniques and mass spectrometric analysis, and the absolute configurations of compounds 1–3 were confirmed as R by comparing the optical rotations with (+)-sydonic acid, while compound 4 was confirmed as S using the same method. The antibacterial, cytotoxic, antifouling, and acetylcholinesterase inhibitory activities of these compounds (1–5) were examined. Compounds 1–5 exhibited selective antibacterial activity against six pathogenic bacteria and two marine bacteria. Compound 4 showed a significant inhibitory effect on larval settlement of the barnacle Balanus amphitrite, while compound 5 was found to have an obvious toxic effect on the larvae. 2. Results and Discussion Aspergiterpenoid A (1) was isolated as optically active white powder, [α]25 −4.7 (c 3.21, CHCl ). D 3 The molecular formula of C H O was confirmed by HREIMS that displayed an [M]•+ m/z of 236.1769 15 24 2 (calcd. 236.1771). The IR absorption bands indicated the existence of hydroxyl functionality (3397 cm−1). The 1H NMR spectrum of 1 showed two exchangeable proton signals at δ 1.66 and 1.71 (validated by H D O change assay), one A B spin system assignable to a 1,4-disubstitued benzene ring at δ 7.43 (2H, 2 2 2 H dd, 8.4, 1.8), 7.34 (2H, dd, 8.4, 1.8) (Table 1). The 1H NMR spectrum revealed the presence of other Mar. Drugs 2012, 10 236 signals including two doublet methyl groups [H -12 (δ 0.81), H -13 (δ 0.81), one singlet methyl group 3 H 3 H [H -14 (δ 1.55)], four methylenes [H -15 (δ 4.69), H -8 (δ 1.77), H -9 (δ 1.12 and 1.26), and H -10 3 H 2 H 2 H 2 H 2 (δ 1.12)], and one methine [H-11 (δ 1.47)]. Thirteen carbon signals observed in the 13C NMR H H spectrum (Table 1) indicated that there is a 1,4-disubstitued benzene ring in compound 1. Detailed analysis of the 1H and 13C NMR spectra revealed that 1 is a bisabolane-type sesquiterpenoid, which is similar to sydonol [15]. The main difference between the spectra of 1 and sydonol was the A B spin 2 2 system in 1 instead of ABX spin system in sydonol, suggesting that the phenolic hydroxyl group was missing in 1. Detailed assignments for carbons and protons were unambiguously accomplished by analysis of 2D NMR spectral data, and the planar structure of 1 was confirmed and is shown in Figure 1. Interestingly, the optical rotation value for 1 was [α]25 −4.7 (c 3.21, CHCl ), contrary to that of sydonol D 3 ([α]20 +7.2 (c 1.0, MeOH)) [15]. On the basis of the absolute configurations of the co-metabolites 2 D and 3 and a shared biogenesis with these two compounds, the configuration of 1 should be assigned as 7R. It is noteworthy to mention that metabolite 1 represents the rare example of a bisabolane-type sesquiterpenoid possessing a 1,4-disubstitued benzene ring isolated from marine organisms. Table 1. NMR spectroscopic data (600 MHz, CDCl ) of Aspergiterpenoid A (1). 3 Position δ , mult δ (J in Hz) C H 1 147.8, C – 2 125.1, CH 7.43, dd (8.4, 1.8) 3 127.0, CH 7.34, dd (8.4, 1.8) 4 139.1, C – 5 127.0, CH 7.34, dd (8.4, 1.8) 6 125.1, CH 7.43, dd (8.4, 1.8) 7 74.8, C – 8 44.4, CH 1.77, m 2 9 21.8, CH 1.26, m; 1.12, overlapped 2 10 39.3, CH 1.12, overlapped 2 11 27.9, CH 1.47, m 12 22.6, CH 0.81, d (6.6) 3 13 22.7, CH 0.81,d (6.6) 3 14 30.3, CH 1.55, s 3 15 65.2, CH 4.69, d (3.0) 2 7–OH 1.71, s 15–OH 1.66, brs Mar. Drugs 2012, 10 237 Figure 1. Structures of compounds 1–5. 4 HOOC HO15 HO 10 7 12 1 2 14 OH OH OH OH OH 13 1 2 3 HO HO O OH OH 4 5 The spectroscopic data of compounds 2 and 3 were almost identical to those of (+)-sydonol and (+)-sydonic acid, respectively. Their opposite optical rotation values indicated that 2 and 3 were the enantiomers of (+)-sydonol and (+)-sydonic acid, respectively. (+)-Sydonol possessing the positive optical rotation value, ([α]20 +7.2 (c 1.0, MeOH)), was isolated from a terrestrial Aspergillus sp. D by Nukina and co-workers in 1981 and exhibited antifungal activity against Cochliobolus lunata (IFO6299) [15]. Sydonic acid was isolated from the fungus A. sydowi in 1978 as a racemate [16], while (+)-sydonic acid ([α]25 +2.73 (c 2.30, MeOH)) was isolated from Glonium sp. in 2009 [17]. However, D in our case, the optical rotation values of 2 and 3 were [α]25 −3.6 (c 3.70, CHCl ) and [α]25 −2.0 D 3 D (c 1.03, CHCl ), respectively. Since there was only one chiral carbon in every compound, the absolute 3 configuration of these two compounds (2 and 3) were also established to be R. Interestingly, (+)-sydonic acid had also been recently isolated from a coral-derived Aspergillus sp. [5], this fact suggested that fungus isolated from different marine organisms might produce different stereochemistry compounds. (−)-5-(Hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H-pyran-2-yl)phenol (4) was identified as the enantiomer of deoxygenated (+)-sydonol, which was a stereoselective synthesis product possessing the positive optical rotation value, [α]20 +40 (c 2.2, CHCl ) [18]. This compound was also isolated from D 3 the fungus Pinus strobus in 2011 as a racemate [14]. In this study, the optical rotation of 4 was detected as [α]25 −2.7 (c 1.05, CHCl ). As there was just one chiral carbon, the absolute stereochemistry of 4 was D 3 established to be S. The antibacterial activity of compounds 1–5 was evaluated by the microplate assay [19] against eight bacterial strains, e.g., six pathogenic bacteria Staphylococcus albus, Bacillus subtilis, Bacillus cereus, Sarcina lutea, Escherichia coli, Micrococcus tetragenus, and two marine bacterial strains Vibrio Parahaemolyticus and Vibrio anguillarum (Table 2). Compound 1 showed weak antibacterial activity against E. coli and M. tetragenus. Compounds 2 and 4 exhibited selective antibacterial activity. Compound 2 exhibited strong inhibitory activity on S. albus and M. tetragenus with the MIC (minimum inhibiting concentrations) values of 5.00 and 1.25 µM, respectively, and 4 on S. albus and B. subtilis with the MIC values of 5.00 and 2.50 µM, respectively. Compounds 3 and 5 showed a broad spectrum of antibacterial activity. Compound 5 inhibited five pathogenic bacteria except for S. lutea, and 3 exhibited significant inhibiting activity to four pathogenic bacteria and uniquely against two marine bacteria, Mar. Drugs 2012, 10 238 especially to S. lutea with the MIC value of 2.50 µM, which was similar to ciprofloxacin used as a positive control. Table 2. Tests of MIC (μM) for compounds 1–5 against eight bacteria. Compounds Strains 1 2 3 4 5 Ciprofloxacin Staphylococcus albus >20.0 5.00 >20.0 5.00 20.0 0.312 Bacillus subtilis >20.0 >20.0 2.50 2.50 10.0 1.25 Bacillus cereus >20.0 >20.0 >20.0 >20.0 10.0 0.625 Sarcina lutea >20.0 >20.0 2.50 >20.0 >20.0 2.50 Escherichia coli 20.0 20.0 5.00 >20.0 10.0 0.625 Micrococcus tetragenus 10.0 1.25 20.0 >20.0 10.0 0.312 Vibrio Parahaemolyticus >20.0 >20.0 10.0 >20.0 >20.0 0.160 Vibrio anguillarum >20.0 >20.0 5.00 >20.0 >20.0 0.160 The isolated compounds 1–5 were also evaluated against the larval settlement of the barnacle Balanus amphitrite according to literature procedures [20]. Compound 4 inhibited larval settlement completely at a concentration of 25.0 μg/mL. However, compound 5 was found to have an obvious toxic effect on the larvae at this concentration. The other three compounds did not display antifouling activity at the same concentration. This is the first report of antifouling activity for this class of metabolites. Compounds 1–5 were found to be weakly cytotoxic (IC > 50 μg/mL) against HL-60 human 50 promyelocytic leukemia and A-549 human lung carcinoma cell lines. The acetylcholinesterase inhibitory activity of compounds 1–5 was also evaluated, but none of the compounds exhibited obviously inhibitory activity. 3. Materials and Methods 3.1. General Experimental Procedures Optical rotations were measured on a JASCO P-1020 digital polarimeter. IR spectra were recorded on a Nicolet Nexus 470 spectrophotometer. 1H and 13C NMR spectra were recorded on a JEOL Eclips-600 spectrometer at 600 MHz for 1H and 150 MHz for 13C in CDCl or DMSO-d . Chemical shifts δ are 3 6 reported in ppm, using TMS as internal standard and coupling constants (J) are in Hz. ESIMS and HRESIMS and APCIMS were measured on a Q-TOF Ultima Global GAA076 LC mass spectrometer. HREIMS were measured on a Thermo MAT95XP High Resolution mass spectrometer and EIMS spectra on a Thermo DSQ EI-mass spectrometer. Silica gel (Qing Dao Hai Yang Chemical Group Co.; 200–300 mesh), octadecylsilyl silica gel (Unicorn; 45–60 μm) and Sephadex LH-20 (Amersham Biosciences) were used for column chromatography (CC). Precoated silica gel plates (Yan Tai Zi Fu Chemical Group Co.; G60, F-254) were used for thin layer chromatography (TLC). Semi-preparative HPLC was performed on a Waters 1525 system using a semi-preparative C18 (Kromasil 7 μm, 10 × 250 mm) column coupled with a Waters 2996 photodiode array detector, at a flow rate of 2.0 mL/min. Mar. Drugs 2012, 10 239 3.2. Fungal Material The fungal strain Aspergillus sp. was isolated from a piece of tissue from the inner part of the freshly collected sponge Xestospongia testudinaria, which was collected from the Weizhou coral reef in the South China Sea in September, 2008. The strain was deposited in the Key Laboratory of Marine Drugs, the Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, PR China, with the access code ZJ-2008004. The fungal strain was cultivated in 50 L liquid medium in 125 Erlenmeyer flasks each containing 400 mL medium (10.0 g of glucose, 2.0 g of yeast extract, 2.0 g of peptone in 1 L of seawater) at 27 °C without shaking for 4 weeks. 3.3. Identification of Fungus The fungus was identified according to its morphological characteristics and a molecular biological protocol by 16s RNA amplification and sequencing of the ITS region. The sequence data have been submitted to GenBank, accession number HM565949. The fungal strain was identified as Aspergillus sp. 3.4. Extraction and Isolation The fungal cultures were filtered through cheesecloth, and the filtrate was extracted with EtOAc (3 × 50 L, 12 h each). The organic extracts were concentrated in vacuo to yield an oily residue (3.2 g), which was subjected to silica gel column chromatography using mixtures of petroleum ether and ethyl acetate to yield five fractions (Fr.1–Fr.5). Fr.2 was further purified by Sephadex LH-20 chromatography eluting with mixtures of CHCl and MeOH (1:1), and then using semi-preparative HPLC with a C18 3 (Kromasil 7 μm, 10 × 25 mm) column at a flow rate of 2.0 mL/min (7:3 MeOH/H O; UV detection at 2 210 nm, t of 1: 25–26 min, 2: 24–25 min) to yield compounds 1 (6.7 mg) and 2 (2.7 mg). Fr.3 was R further purified by Sephadex LH-20 chromatography with mixtures of petroleum ether-CHCl -MeOH 3 (2:1:1) and CHCl -MeOH (1:1) to obtain compounds 3 (50.6 mg), 4 (8.0 mg) and 5 (7.5 mg). 3 Aspergiterpenoid A (1): white powder; [α]25 −4.7 (c 3.21, CHCl ); UV (MeOH) λ 194.6, 216.9, D 3 max 260.4 nm; IR (KBr) ν 3397, 3115, 2946, 2872, 1696, 1647, 1016, 803 cm−1; 1H and 13C NMR see max Table 1; APCIMS m/z 235.1 [M − H]−; HREIMS m/z 236.1769 [M]•+ (calcd. for C H O , 236.1771). 15 24 2 (−)-Sydonol (2): white powder; [α]25 −3.6 (c 3.70, CHCl ); UV (MeOH) λ 198.1, 275.7 nm; D 3 max IR (KBr) ν 3071, 2946, 2860, 1692, 1640, 1533, 1507, 1407, 1288, 1215, 764 cm−1; HREIMS max m/z 252.1719 [M]•+ (calcd. for C H O , 252.1720). 15 24 3 (−)-Sydonic acid (3): white powder; [α]25 −2.0 (c 1.03, CHCl ); UV (MeOH) λ 206.3, 253.3, D 3 max 304.2 nm; IR (KBr) ν 3400, 2955, 1670, 1560, 1417, 1325 cm−1; HREIMS m/z 266.1512 [M]•+ max (calcd. for C H O , 266.1513). 15 22 4 (−)-5-(Hydroxymethyl)-2-(2′,6′,6′-trimethyltetrahydro-2H-pyran-2-yl)phenol (4): white powder; [α]25 −2.7 (c 1.05, CHCl ); UV (MeOH) λ 198.1, 280.5 nm; IR (KBr) ν 3272, 3115, 3039, 2949, D 3 max max 2872, 1866, 1696, 1619, 1288 cm−1; HRESIMS m/z 249.1497 [M − H]− (calcd. for C H O , 249.1491). 15 21 3 Mar. Drugs 2012, 10 240 (Z)-5-(Hydroxymethyl)-2-(6′-methylhept-2′-en-2′-yl)phenol (5): white powder; UV (MeOH) λ 198.1, 236.4, 280.5 nm; IR (KBr) ν 3272, 3115, 3039, 3005, 1866, 1745, 1647, 1288 cm−1; max max HRESIMS m/z 233.1540 [M − H]− (calcd. for C H O , 233.1542). 15 21 2 4. Conclusions In our continuing discovery for biological secondary metabolites from marine sponge-derived fungi in the South China Sea, this study provided a series of bisabolane-type sesquiterpenoids. The chiral compounds (1–4) possess opposite optical rotation values compared with their related analogues, which were isolated from the gorgonian-derived fungi by our group. More importantly, some of them showed selective antibacterial activity and significant antifouling activity. Compound 3 exhibited significant inhibiting activity to four pathogenic bacteria and uniquely against two marine bacteria. Further studies on the structure-activity relationship and structural modification are in progress. Acknowledgements This work was supported by the Key Program of National Natural Science Foundation of China (No. 41130858), the National Natural Science Foundation of China (No. 40776073; 40976077; 30901879), the Research Fund for the Doctoral Program of Higher Education, Ministry of Education of China (No. 20090132110002), and the Project of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China (CMEMR2011-08). References 1. D’Armas, H.T.; Mootoo, B.S.; Reynolds, W.F. An unusual sesquiterpene derivative from the caribbean gorgonian Pseudopterogorgia rigida. J. Nat. Prod. 2000, 63, 1593–1595. 2. Sugahara, T.; Ogasawara, K. A new stereocontrolled route to (+)-curcuphenol, a phenolic sesquiterpene from the marine sponge Didiscus flavus. Tetrahedron 1998, 9, 2215–2217. 3. Peng, J.N.; Franzblau, S.G.; Zhang, F.Q.; Hamann, M.T. Novel sesquiterpenes and a lactone from the Jamaican sponge Myrmekioderma styx. Tetrahedron Lett. 2002, 43, 9699–9702. 4. Celso, A.; Somaia, E.; Stefan, K.; Koenig, G.M. Novel bisabolane sesquiterpenes from the marine-derived fungus Verticillium tenerum. Nat. Prod. Commun. 2010, 5, 507–510. 5. Wei, M.Y.; Wang, C.Y.; Liu, Q.A.; Shao, C.L.; She, Z.G.; Lin, Y.C. Five sesquiterpenoids from a marine-derived fungus Aspergillus sp. isolated from a gorgonian Dichotella gemmacea. Mar. Drugs 2010, 8, 941–949. 6. Trisuwan, K.; Rukachaisikikul, V.; Kaewpet, M.; Phongpaichit, S.; Hutadilok-Towatana, N.; Preedanon, S.; Sakayaroj, J. Sesquiterpene and xanthone derivatives from the sea fan-derived fungus Aspergillus sydowii PSU-F154. J. Nat. Prod. 2011, 74, 1663–1667. 7. Fujiwara, M.; Yagi, N.; Miyazawa, M. Acetylcholinesterase inhibitory activity of volatile oil from Peltophorum dasyrachis Kurz ex Bakar (yellow batai) and bisabolane-type sesquiterpenoids. J. Agric. Food Chem. 2010, 58, 2824–2829. Mar. Drugs 2012, 10 241 8. Takamatsu, S.; Hodges, T.W.; Rajbhandari, I.; Gerwick, W.H.; Hamann, M.T.; Nagle, D.G. Marine natural products as novel antioxidant prototypes. J. Nat. Prod. 2003, 66, 605–608. 9. Huo, J.; Yang, S.P.; Xie, B.J.; Liao, S.G.; Lin, L.P.; Ding, J.; Yue, J.M. Cytotoxic sesquiterpenoids from Vernonia bockiana. J. Asian Nat. Prod. Res. 2008, 10, 571–575. 10. Mcenroe, F.J.; Fenical, W. Structures and synthesis of some new antibacterial sesquiterpenoids from the gorgonian coral Pseudopterogorgia rigida. Tetrahedron 1978, 34, 1661–1164. 11. Shao, C.L.; Wang, C.Y.; Gu, Y.C.; Wei, M.Y.; Pan, J.H.; Deng, D.S.; She, Z.G.; Lin, Y.C. Penicinoline, a new pyrrolyl 4-quinolinone alkaloid with an unprecedented ring system from an endophytic fungus Penicillium sp. Bioorg. Med. Chem. Lett. 2010, 20, 3284–3286. 12. Shao, C.L.; Wang, C.Y.; Wei, M.Y.; Gu, Y.C.; She, Z.G.; Qian, P.Y.; Lin, Y.C. Aspergilones A and B, two benzylazaphilones with an unprecedented carbon skeleton from the gorgonian-derived fungus Aspergillus sp. Bioorg. Med. Chem. Lett. 2011, 21, 690–693. 13. Shao, C.L.; Wu, H.X.; Wang, C.Y.; Liu, Q.A.; Xu, Y.; Wei, M.Y.; Qian, P.Y.; Gu, Y.C.; Zheng, C.J.; She, Z.G.; et al. Potent antifouling resorcylic acid lactones from the gorgonian-derived fungus Cochliobolus lunatus. J. Nat. Prod. 2011, 74, 629–633. 14. Sumarah, M.W.; Kesting, J.R.; Sørensen, D.; Miller, J.D. Antifungal metabolites from fungal endophytes of Pinus strobus. Phytochemistry 2011, 72, 1833–1837. 15. Nukina, M.; Sato, Y.; Ikeda, M.; Sassa, T. Sydonol, a new fungal morphogenic substance produced by an unidentified Aspergillus sp. Agric. Biol. Chem. 1981, 45, 789–790. 16. Hamasaki, T.; Nagayama, K.; Hatsuda, Y. Two new metabolites, sydonic acid and hydroxysydonic acid, from Aspergillus sydowi. Agric. Biol. Chem. 1978, 42, 37–40. 17. Kudo, S.; Murakami, T.; Miyanishi, J.; Tanaka, K.; Takada, N.; Hashimoto, M. Isolation and absolute stereochemistry of optically active sydonic acid from Glonium sp., (Hysteriales, Ascomycota). Biosci. Biotechnol. Biochem. 2009, 73, 203–204. 18. Serra, S. Bisabolane sesquiterpenes: Synthesis of (R)-(+)-sydowic acid and (R)-(+)-curcumene ether. Syn. Lett. 2000, 6, 890–892. 19. Pierce, C.G.; Uppuluri, P.; Teistan, A.R.; Wormley, F.L., Jr.; Mowat, E.; Ramage, G.; Lopez-ribot, J.L. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 2008, 3, 1494–1500. 20. Qi, S.H.; Zhang, S.; Qian, P.Y.; Xiao, Z.H.; Li, M.Y. Ten new antifouling briarane diterpenoids from the South China Sea gorgonian Junceella juncea. Tetrahedron 2006, 62, 9123–9130. Samples Availability: Available from the authors. © 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).